May 22, 2025, 22:48

MRC Partnership Grant

The Medical Research Council (MRC) Partnership Grant supports the creation of new, high-value collaborative partnerships between diverse research teams in areas including infections and immunity, molecular and cellular medicine, neurosciences and mental health, and population and systems medicine. These partnerships are not for conducting research directly, but to enhance scientific programs through infrastructure, training, networking, and capacity building.

Eligibility Criteria:

Applicants must be based at an MRC-eligible UK research organization
Must have completed the pre-application process and received an invitation to submit a full application
Must propose a novel partnership that enhances existing high-quality scientific programs
International researchers may participate as co-leads (international)
Project leads from MRC institutes or international institutions (excluding MRC Units in The Gambia and Uganda) are not eligible

Funding Details:

Duration: 1 to 5 years
No fixed funding cap; costs must be appropriate and well justified
MRC funds 80% of full economic costs and 100% of permitted exceptions
Costs can include salaries, technical staff, infrastructure, travel, equipment, and public engagement
Research projects themselves are not funded unless small-scale, high-risk pilot activities

Deadline:

4 September 2025 at 4:00 PM UK time

(Pre-application required by 7 July 2025)

Where to Go for Further Information:

Official Page: https://www.ukri.org/opportunity/mrc-partnership-grant

Email Contacts (based on domain):

[email protected] – Infections and Immunity
[email protected] – Molecular and Cellular Medicine
[email protected] – Neurosciences and Mental Health
[email protected] – Population and Systems Medicine

Helpdesk: [email protected]

academic networks biomedical collaborations cancer cancer strategy uk health systems medicine infrastructure funding interdisciplinary cancer research Medical Research Council Molecular Medicine mrc partnership grant neuroscience collaboration OncoDaily Oncology research capacity building translational partnerships uk biomedical funding ukri funding

25 Posts Not To Miss From ESMO GI 2025

Botensilimab and Balstilimab Show Durable Survival in MSS Colorectal Cancer: ESMO GI 2025 Update

Julian McMahon Dies at 56: A Look Back at His Private Cancer Battle and Legendary Acting Career

Vivek Subbiah: It’s Time We Evolve WHO Cancer Classification

ESMO 50th Anniversary: Half a Century of Evidence-Based Cancer Care